Your position: Home > enterprise strength

       Based on the strategy of "National Science and technology center, pharmaceutical industry innovation center" and "Pharmaceutical Technology Innovation Center", lubonan group has been taking "scientific and technological innovation as the main body, scientific and technological innovation center as the main body, and pharmaceutical industry as the main force The National Engineering Laboratory for cell efficient expression, the State Key Laboratory for generic technology of traditional Chinese medicine, Taishan scholar posts, academician workstation and other research and development platforms have formed an innovative R & D team with doctors and masters as the backbone.

       Science and technology are the first productivity, and independent innovation is the first competitiveness. While establishing its own scientific research team, Lunan Pharmaceutical Group has also established Luhua Biotechnology Research Institute with East China University of science and technology, Shandong University, Shandong University, and Shanghai Pharmaceutical Industry Research Institute More than 80 pharmaceutical research centers such as Jinan University and Lunan Institute of pharmaceutical technology have been established in cooperation with Jinan University and Lunan Institute of pharmaceutical technology.

       In recent years, the company has undertaken more than 300 research projects, including more than 50 national science and technology support plan, National 863 plan, national 973 Plan, national major new drug creation special project, national torch plan, national key new product plan, etc. 120 scientific and technological achievements have been appraised by experts, 45 have reached the international advanced level, 61 have reached the domestic leading level, and 131 science and technology awards have been given, Among them, there are 1 National Technological Invention Award, 7 second prize of national science and technology progress award, and 22 science and technology awards of Shandong Province. In recent years, it has applied for 1169 international and domestic invention patents, and 659 authorized patents. The number of authorized patents ranks the second among domestic pharmaceutical enterprises. It has won the title of "the first top ten industrial enterprises with the best R & D product line of domestic pharmaceutical". It has applied for 2580 registered trademarks, and has obtained 2128 registration certificates, ranking first in Shandong Province.   


 R & D platform-01-littlenew.png